Greg Lohman
Greg Lohman leads a research group at New England Biolabs within the Applied Molecular Biology Research Division. He started his career as an organic chemist at MIT, later switching to a biochemistry focus under Joanne Stubbe. Joining New England Biolabs as a postdoctoral researcher in 2010, he studied DNA ligase mechanism, structure-function relationships and substrate specificity. This line of research continued as he founded his own group within NEB, and informed recent work to push the limits of in vitro DNA assembly and other molecular biology applications. Success in developing design approaches for high-complexity Golden Gate Assembly has led to a further evolution of his research interests into synthetic biology, with the application of DNA assembly approaches to synthetic genomics and bacteriophage engineering. Greg’s work as an individual contributor and a principal investigator has resulted in to over 20 peer-reviewed publications, several patents, and multiple products in the NEB catalog.
New England Biolabs
Pushing Boundaries: How Reliable DNA Synthesis is Accelerating Innovation in Cell and Gene Therapy
-
Join leading scientists as they share how increased reliability in DNA synthesis services is transforming the way they work—empowering them to confidently expand their design space, accelerate project timelines, and drive innovation in vaccine development and cell and gene therapies. Scientists will talk about their experiences with vector onboarding, synthesis of long and complex sequences, and chromosomal and genome engineering.
